This information is intended for use by health professionals
| Thiamine hydrochloride BP
| Riboflavin BP
| Pyridoxine hydrochloride
| Nicotinamide BP
| Calcium pantothenate PhEur
| Ascorbic acid BP
| Acetomenaphthone BP 1973
| Alpha-tocopheryl acetate BP
| Inositol NF XII
| Biotin USP
| Folic acid BP
As a therapeutic supplement for the prevention of vitamin deficiency in conditions such as galactosaemia, disaccharide intolerance, phenylketonuria and other disorders of carbohydrate or amino acid metabolism, as well as in patients who are on restricted, specialised or synthetic diets.
In order to achieve complete vitamin supplementation Ketovite Tablets should be used in conjunction with Ketovite Liquid.
For Adults, Children and the Elderly:
One tablet three times a day, by oral administration.
Hypersensitivity to the product.
Pyridoxine may increase the peripheral metabolism of levodopa reducing therapeutic efficacy in patients with Parkinson's disease.
The recommended dose should not be exceeded without medical advice.
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.
Large overdoses of water-soluble vitamins are readily excreted in the urine. No emergency procedure or antidote is applicable and any symptoms are rapidly reduced upon withdrawal of the preparation.
In normal circumstances the active constituents are obtained by the same route of administration (oral) from food.
No relevant pre-clinical data has been generated.
Heavy magnesium carbonate
Colloidal silicon dioxide
Securitainers containing 84, 90, 100 or 500 tablets.
Essential Pharmaceuticals Limited
Unit 7, Egham Business Village
Surrey TW20 8RB,
27 March 1987; renewed 29 June 1999